What to know about the new Alzheimer's drug

Dr. Bruno Giordani said a new drug, Leqembi, targets the proteins that scientists think are responsible for the disease.

Professor of Psychology in Psychiatry, Neurology, and Psychology

Chief Psychologist, Department of Psychiatry

Senior Director of the Mary A. Rackham Institute (MARI)

Associate Director for Michigan’s Alzheimer’s Disease Center